and by determination of acetylcholine receptor antibodies." All patients had normal serum creatinine levels and none showed clinical signs of liver disease. Methods Serum Mb was assayed by means of a solid-phase radioimmunoassay described earlier.12 Each serum sample was assayed in duplicate. The within-day variation was 8% (coefficient of variation).
polymyositis and the diagnosis of myasthenia gravis was confirmed by the typical case history, a positive response to edrophonium, single fibre EMG (by StAlberg'0) and by determination of acetylcholine receptor antibodies." All patients had normal serum creatinine levels and none showed clinical signs of liver disease. Methods Serum Mb was assayed by means of a solid-phase radioimmunoassay described earlier. 12 Each serum sample was assayed in duplicate. The within-day variation was 8% (coefficient of variation).
The normal values for serum Mb, in a reference material of 99 blood donors of ages 20-62 years, was 35-7 ,ug/l ±20-8 (mean ±2 SD) for women and 50 6 ug/l ±39-6 (mean ±2 SD) for men.'2 Serum CK determinations were performed at the routine laboratory. The upper normal limit (+ 2 SD) was 2 5 gkat/l (2-5 umol per second per litre, ,umol s-' 1-1).
Results
The serum concentrations of Mb and the number of patients with elevated Mb and serum CK levels are given in fig 1 and table 1 of the were demonstrated and eight patients also had e of the patients with polymyositis were antibodies against striated muscle. Eight of the ated with steroids and these patients patients were treated with steroids. Normal Mb al CK levels. levels were found in 13 of the patients with Mb was determined on several occasions myasthenia gravis. In this group two patients had :eriod of 6-33 months in seven patients severe generalised myasthenia (Osserman 2B and myositis. In six of them there was a 3, respectively), but only one patient had distion between Mb levels, CK levels and abling symptoms at the time of the study. The ourse as exemplified in figs 2 and 3. The other 11 patients had mild generalised myas-:s declined within a few weeks after thenia. Thymectomy had been performed in L of steriod therapy, slightly prior or of the 13 patients and thymoma had been found iith the clinical improvement, and in in one case. Acetylcholine receptor antibodies In our study, 26 of 28 patients (93 %) with myogenic myopathy had raised Mb levels. This group included 11 patients with polymyositis and in all of these the serum Mb was increased. This finding is in accordance with the report of M'iyoshi et al,7 who investigated 20 patients with myogenic myopathy (six with polymyositis and 14 with Duchenne's muscular dystrophy), and found elevated Mb levels in all of them. Hische and Van der Helm reported that the serum Mb levels were raised in 54% of patients with neuromuscular diseases.8 Eight of nine patients with untreated polymyositis had elevated Mb levels and such an increase was found in 74 % of all the patients with myogenic myopathy. Using a solid-phase radioimmunoassay very similar to ours, Nishikai and Reichlin6 noted increas-ed serum Mb in only 50 % of patients wi-th polymyositis and in 38% with muscular dystrophy. The use of different normal values of serum Mb might conceivably contribute to this discrepancy, but it is difficult to explain the difference between their results and ours. Contrary to Nishikai and Reichlin we have not used the same normal values for men and women, as there is a significant difference in serum Mb levels between healthy men and women.'2 In polymyositis one other explanation might be a difference in the treatment of the patients at the time of the sampling.
The results of the present investigation indicate that radioimmunoassay of serum Mb is a more sensitive method for detection of muscle disease than determination of CK. Only two of 28 patients with myogenic myopathy had normal Mb levels, whereas normal serum CK was noted in 11 patients in this group. Consequently, the finding of a normal serum Mb does not exclude, but considerably reduces the probability of a myogenic myopathy.
Nishikai and Reichlin6 noted elevated Mb levels in five of 13 patients (38%) with myasthenia gravis and in our study 15 of 28 patients (54%) with this disease had raised Mb levels. In myasthenia gravis elevated CK levels are seldom found (in our material four of 83 patients with myasthenia gravis had elevated serum CK). This discrepancy between Mb and CK levels in patients with myasthenia gravis indicates a selective leakage of low molecular weight protein from the muscle cell. There were more patients with severe forms of myasthenia (Osserman 2B, 3, 4) in the group with elevated Mb and this group had also higher concentrations of acetylcholine receptor antibodies. We found no distinct relationship, however, between Mb levels and the clinical condition at the time of sampling.
In conclusion radioimmunoassay of serum Mb appears to be valuable as a supplementary tool to detect the presence of a myopathy and also seems useful for evaluating the status and therapeutic result in polymyositis. Serum Mb seems to be a more sensitive indicator of muscle disease than CK, and a normal serum Mb level in a patient not treated with steroids will considerably decrease the probability of a myogenic myopathy. Further study is needed to find out whether Mb determinations might also be of practical valu-e in myasthenia gravis.
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